CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $677 | -71.1% | 24,832 | -76.4% | 0.01% | -68.4% |
| Q2 2023 | $2,339 | +91.4% | 105,110 | +86.3% | 0.02% | +90.0% |
| Q1 2023 | $1,222 | +44.4% | 56,409 | +35.4% | 0.01% | -16.7% |
| Q4 2022 | $846 | -99.8% | 41,654 | +116.8% | 0.01% | +100.0% |
| Q2 2022 | $457,000 | -76.9% | 19,210 | -78.1% | 0.01% | -76.0% |
| Q1 2022 | $1,976,000 | +29.6% | 87,754 | +13.9% | 0.02% | +56.2% |
| Q4 2021 | $1,525,000 | +263.1% | 77,027 | +379.8% | 0.02% | +300.0% |
| Q4 2020 | $420,000 | -44.7% | 16,053 | -63.2% | 0.00% | -73.3% |
| Q3 2020 | $759,000 | +69.0% | 43,590 | +17.4% | 0.02% | +87.5% |
| Q4 2019 | $449,000 | +43.9% | 37,139 | +68.3% | 0.01% | -27.3% |
| Q3 2019 | $312,000 | – | 22,065 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |